May 07, 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
May 07, 2018
Amneal and Impax Complete Business Combination
Apr 30, 2018
$20 Million Class Action Settlement has been Reached for Purchasers of Solodyn®
Apr 27, 2018
Amneal And Impax Receive FTC Clearance For Business Combination
Apr 27, 2018
ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax
Apr 06, 2018
Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)
Apr 05, 2018
If You Purchased Solodyn® and/or Its Generic Equivalent You Could Get Money from a Class Action Lawsuit Settlement
Mar 27, 2018
Impax Shareholders Approve Proposed Business Combination with Amneal
Mar 07, 2018
Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference
Mar 01, 2018
Impax Reports Fourth Quarter and Full Year 2017 Results
Mar 01, 2018
Amneal Launches Generic for Tamiflu® Oral Suspension
Feb 20, 2018
Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets
Feb 06, 2018
Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations
Feb 05, 2018
Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta®
Jan 30, 2018
CorePharma, LLC Acquired by Investor Group
Jan 24, 2018
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace® Cream
Jan 16, 2018
Impax to Report Fourth Quarter and Full Year 2017 Results on March 1, 2018
Jan 03, 2018
Amneal Pharmaceuticals and Impax Laboratories to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 19, 2017
Impax Announces Sale of Taiwan Manufacturing Facility
Dec 18, 2017
Robert Stewart to Join Amneal Pharmaceuticals as President